Health Catalyst (HCAT) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Health Catalyst (HCAT) over the last 7 years, with Q3 2025 value amounting to -$0.32.
- Health Catalyst's EPS (Weighted Average and Diluted) fell 3333.33% to -$0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.59, marking a year-over-year decrease of 1865.67%. This contributed to the annual value of -$1.15 for FY2024, which is 4474.61% up from last year.
- As of Q3 2025, Health Catalyst's EPS (Weighted Average and Diluted) stood at -$0.32, which was down 3333.33% from -$0.59 recorded in Q2 2025.
- Health Catalyst's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.23 during Q2 2024, with a 5-year trough of -$0.96 in Q4 2021.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.58 (2023), whereas its average is -$0.55.
- In the last 5 years, Health Catalyst's EPS (Weighted Average and Diluted) surged by 6034.48% in 2024 and then crashed by 15652.17% in 2025.
- Quarter analysis of 5 years shows Health Catalyst's EPS (Weighted Average and Diluted) stood at -$0.96 in 2021, then surged by 31.25% to -$0.66 in 2022, then grew by 21.21% to -$0.52 in 2023, then surged by 33.94% to -$0.34 in 2024, then rose by 6.84% to -$0.32 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.32 for Q3 2025, versus -$0.59 for Q2 2025 and -$0.35 for Q1 2025.